is, was PTSC representing to Shareholders that they owned all the patent Rights, when they perhaps knew they didn't, and that Shareholder's only found out differently when TPL and Moore publicly came knocking sometime back in 2003/4 ?

Why was there no mention of a Co-patent holder in any PTSC investors materials that I am aware of prior to the Tender offer, Patent purchase offer, and litigation with TPL/Moore ?

As far as I recall in the public materials made available, why, when back in 2001 with the formal and widely announced IP Evaluation of PTSC covering our patents (the MMP) by Dr. Koury and Inavasis, was there no mention of a Co patent holder, no mention that the commercial valuation from licensing of the PTSC patents was something that could be reduced by paying fees to others besides PTSC ???

I believe the full Inavasis patent evaluation report was never released publically, but Dr Khoury did speak at a Shareholder meeting to share his findings, and PTSC did release the general results of his evaluation in a PR.. at no time do I recall hearing or seeing in print that we were only Co-patent holders referened or discussed at that time.

What did the full non public report to PTSC say ? Did it discuss that we were only Co-Patent holders, and that we didn't own it exclusively ? Would a formal "Evaluation" of this type by a professional of this caliber NOT at least contain the basic recognition within the document that there was another Co Owner ???. Did the full Koury report identify another Co Owner, and if it did, did PTSC have an obligation to make that revelation Public to it's Shareholders at that point ???

( BW)(CA-PATRIOT-SCIENTIFIC)(PTSC) PTSC Retains Inavisis, Inc., to Evaluate Its Technology Assets; Setting Market Value of Patents & Intellectual Property is Goal

Business Editors

SAN DIEGO--(BUSINESS WIRE)--Oct 12, 2001--PTSC (Patriot Scientific Corp.)(OTCBB: PTSC) has retained Inavisis, Inc., an experienced, San Diego-based consulting firm, to complete an independent evaluation of its intellectual property assets.
The Intellectual property evaluation consulting team is led by Inavisis' Founder and President, Dr. Sam Khoury who currently serves as a trustee of the Licensing Executives Society. He has been manager and appraiser of intellectual assets for The Dow Chemical Company and was directly responsible for generating over $100 million in revenues from Dow's leveraged intellectual properties. Inavisis provides independent third party valuations for US and international intellectual property companies.
"The report from Inavisis, will provide PTSC's management, shareholders and potential customers with an appraisal of the market value of our intellectual property assets," said Mike Korodi, Vice President of Sales and Marketing of PTSC. "The input and assistance from Sam Khoury and his team will be quite a valuable tool to present to potential customers based on feedback we have received from our commercialization efforts thus far."
Mr. Korodi continued, "PTSC has engaged a powerful combination of outstanding talent represented by Dr. Khoury and his team as well as the members of our newly-formed Board of Advisors. We fully intend to capitalize on this pool of expertise and industry contacts as we complete our shift of PTSC's marketing strategy to concentrate on selling licenses to others who incorporate our technology in the design of their products."
Dr. Sam Khoury commented, "We are favorably impressed with the PTSC technologies and the patent portfolio that the company already holds. There are tried and proven methods of leveraging intellectual property assets, and while there are no guarantees, with the advice and introductions to potential customers that we can also provide, we already see considerable potential for PTSC."